SolasCure has completed its second phase 2 clinical trial of Aurase Wound Gel, reporting results that indicate substantially faster healing in patients with chronic venous leg ulcers.
Gilead has released new phase 3 data from its ARTISTRY‑1 and ARTISTRY‑2 trials assessing treatment responses in adults with HIV who are virologically suppressed, including those switching from complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results